Tuberculosis Trials in Kisumu, Kenya
Conditions / Tuberculosis / Kisumu, Kenya
Research into Tuberculosis spans multiple therapeutic approaches and trial phases.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02430506 | A Study to Evaluate Safety and Immunogenicity of AERAS-402 Administered in HIV-negative, BCG-vaccinated, QFT (+) and (-) Adults Without Evidence of TB | COMPLETED | PHASE1 |
| NCT02412436 | PK Study of Rifampicin Interactions With DMPA and Efavirenz in TB | COMPLETED | PHASE2 |
| NCT05845112 | Start Taking Action For TB Diagnosis | COMPLETED | — |
| NCT02027480 | Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study | COMPLETED | — |
| NCT06585683 | Post-Trial Tuberculosis Case Finding: A Substudy of CoVPN 3008 | COMPLETED | — |
| NCT06062238 | Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults | ACTIVE_NOT_RECRUITING | — |
| NCT01755598 | Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults | COMPLETED | PHASE2 |
| NCT01404312 | Brief Rifapentine-Isoniazid Evaluation for TB Prevention (BRIEF TB) | COMPLETED | PHASE3 |
| NCT01198366 | Study of AERAS-402 in Healthy Infants | COMPLETED | PHASE1/PHASE2 |
| NCT02410772 | TBTC Study 31: Rifapentine-containing Tuberculosis Treatment Shortening Regimens | COMPLETED | PHASE3 |